Vimarsana
Biggest News Aggregation in the World

Danielj Kosman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Danielj Kosman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Danielj Kosman Today - Breaking & Trending Today

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 - Vimarsana News

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434

Published: November 16, 2023

MELBOURNE, Australia and SAN FRANCISCO, Nov. 16, 2023 -- Alterity Therapeutics , a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today...

Source: marketscreener.com
Related Topics:
United StatesSan FranciscoHannah HowlettRemy BernardaDanielle BaileyDanielj KosmanDavid StamlerUniversity Of New York At BuffaloAlterity TherapeuticsSociety For NeuroscienceEuropean CommissionSecurities ExchangeMitochondrial Protectant EffectsNovel InhibitorSynuclein AggregationModerate Iron Binding AffinityDistinguished ProfessorState UniversityNew YorkChief Executive OfficerMultiple System AtrophyMultiple SystemMedia ContactsSecurities ActSecurities Exchange Act
Alterity Therapeutics : Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 -November 15, 2023 at 05:54 pm EST - Vimarsana News

Alterity Therapeutics : Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 -November 15, 2023 at 05:54 pm EST

Published: November 15, 2023

Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434 November 16, 2023November 16, 2023 Alterity Therapeutics ...

Source: marketscreener.com
Related Topics:
San FranciscoUnited StatesDanielle BaileyDanielj KosmanDavid StamlerEuropean CommissionSociety For NeuroscienceUniversity Of New York At BuffaloAlterity TherapeuticsMitochondrial Protectant EffectsNovel InhibitorSynuclein AggregationModerate Iron Binding AffinityDistinguished ProfessorState UniversityNew YorkChief Executive OfficerMultiple System AtrophyMultiple System